Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

Completed · Phase 2 · Has a placebo group

Conditions studied: Methamphetamine Dependence

In brief

The purpose of this study will be to examine the safety and efficacy of modafinil in increasing number of methamphetamine non-use weeks in subjects with methamphetamine dependence.

Key facts

Study ID

NCT00520286

Run by

National Institute on Drug Abuse (NIDA)

People needed

210

Starts

2007-12-01

Expected to finish

2010-03-01

Last updated by the study team

2017-04-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must be between the ages of 18 and 65
• Methamphetamine dependent as defined by DSM-IV criteria
• Must be in good general heath with a history of methamphetamine use at screening
• Must be able to provide written informed consent
• If female and of child bearing potential, must agree to use birth control.

You may not qualify if…

• Please contact site for more information

Where it is running

• South Bay Treatment Center — San Diego, California, United States
• Matrix Institute on Addictions — Tarzana, California, United States
• Torrance Site — Torrance, California, United States
• University of Colorado Health Sciences Center — Denver, Colorado, United States
• John A. Burns School of Medicine — Honolulu, Hawaii, United States
• Powell Chemical Dependency Center — Des Moines, Iowa, United States
• START Research and Treatment — Kansas City, Missouri, United States
• Salt Lake City VA Medical Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.